ניופוגן  MU 30 מזרק מוכן לשימוש ישראל - עברית - Ministry of Health

ניופוגן mu 30 מזרק מוכן לשימוש

amgen europe b.v. - filgrastim - תמיסה להזרקה - filgrastim 30 mu / 0.5 ml - filgrastim - filgrastim - - reduction in the duration and severity of neutropenia in patients treated with highly myelosuppressive chemotherapy for malignancy (with the exception of chronic myeloid leukaemia and myelodysplastic syndromes ).- reduction in the duration of neutropenia in patients undergoing high-dose cytotoxic chemotherapy followed by bone marrow transplantation. - in children or adults with severe congenital neutropenia cyclic neutropenia or idiopathic neutropenia a history of clinically important infections within the last 12 months and three documented episodes of neutropenia (with an anc< 5 x 1000000000) long-term administration of neupogen is indicated to increase neutrophil counts and to reduce infections. - neupogen is indicated for the mobilisation of autologous peripheral blood progenitor cells alone or following myelosuppressive chemotherapy and the mobilisation of peripheral blood progenitor cells in normal donors (allogeneic pbpc).

טבעגרסטים ישראל - עברית - Ministry of Health

טבעגרסטים

teva israel ltd - filgrastim - תמיסה להזרקה\אינפוזיה - filgrastim 0.6 mg/ml - filgrastim - filgrastim - tevagrastim is indicated for the reduction in the duration of neutropenia and the incidence of febrile neutropenia in patients treated with established cytotoxic chemotherapy for malignancy (with the exception of chronic myeloid leukaemia and myelodysplastic syndromes ) and for the reduction in the duration of neutropenia in patients undergoing myeloablative therapy followed by bone marrow transplantation considered to be at increased risk of prolonged severe neutropenia. the safety and efficacy of tevagrastim are similar in adults and children receiving cytotoxic chemotherapy. tevagrastim is indicated for the mobilisation of peripheral blood progenitor cells in normal donors (allogeneic pbpc). in patients children or adults with severe congenital neutropenia cyclic or idiopathic neutropenia with an absolute nuetrophil count (anc) less than or equal to 0.5 x 1000000000 /l and a history of severe or recurrent infections long term administration of tevagrastim is indicated to increase neutophil count and to red

אילאריס 150 מגמל ישראל - עברית - Ministry of Health

אילאריס 150 מגמל

novartis israel ltd - canakinumab - אבקה להכנת תמיסה לזריקה - canakinumab 150 mg / 1 ml - canakinumab - canakinumab - cryopyrin - associated periodic syndromes (caps) in adults, adolescents and children aged 2 years and older with body weight above 7.5 kg, including : - mucle - wells syndrome (mws), - neonatal-onset multisystem inflammatory disease (nomid) / chronic infantile neurological, cutaneous, articular syndrome (cinca), - severe forms of familial cold autoinflammatory syndrome (fcas) / familial cold urticaria (fcu) presenting with signs and symptoms beyond cold-induced urticarial skin rash.gouty arthritis:ilaris is indicated for the symptomatic treatment of adults patients with frequent gouty arthritis attacks (at least 3 attacks in the previous 12 months) in whom non-steroidal anti-inflammatory drugs (nsaids) and colchicine are contraindicated, are not tolerated, or do not provide an adequate response, and in whom repeated courses of corticosteroids are not appropriate.

ארטופן 200 מג ישראל - עברית - Ministry of Health

ארטופן 200 מג

teva pharmaceutical industries ltd, israel - ibuprofen - טבליה - ibuprofen 200 mg - ibuprofen - ibuprofen - for the relief of pain such as: headache, toothache, menstrual pain backache muscle ache anti-inflammatory for rheumatic diseases reduction of fever.

אסנטה 5 ישראל - עברית - Ministry of Health

אסנטה 5

padagis israel pharmaceuticals ltd, israel - donepezil hydrochloride - טבליה - donepezil hydrochloride 5 mg - donepezil - donepezil - for the treatment of mild to moderately severe alzheimer's dementia

אסנטה 10 ישראל - עברית - Ministry of Health

אסנטה 10

padagis israel pharmaceuticals ltd, israel - donepezil hydrochloride - טבליה - donepezil hydrochloride 10 mg - donepezil - donepezil - for the treatment of mild to moderately severe alzheimer's dementia

דונפזיל טבע   5 מג ישראל - עברית - Ministry of Health

דונפזיל טבע 5 מג

teva pharmaceutical industries ltd, israel - donepezil hydrochloride - טבליה - donepezil hydrochloride 5 mg - donepezil - donepezil - treatment of mild to moderately severe alzheimer's dementia.

דונפזיל טבע   5 מג ישראל - עברית - Ministry of Health

דונפזיל טבע 5 מג

teva pharmaceutical industries ltd, israel - donepezil hydrochloride - טבליה - donepezil hydrochloride 5 mg - donepezil - donepezil - treatment of mild to moderately severe alzheimer's dementia.

דונפזיל טבע   10 מג ישראל - עברית - Ministry of Health

דונפזיל טבע 10 מג

teva pharmaceutical industries ltd, israel - donepezil hydrochloride - טבליה - donepezil hydrochloride 10 mg - donepezil - donepezil - treatment of mild to moderately severe alzheimer's dementia.

אקסלון   1.5 מג ישראל - עברית - Ministry of Health

אקסלון 1.5 מג

novartis israel ltd - rivastigmine as hydrogen tartrate - קפסולות - rivastigmine as hydrogen tartrate 1.5 mg - rivastigmine - rivastigmine - treatment of patients with mild to moderately severe dementia of the alzheimer type, also termed probable alzheimer's disease or alzheimer's disease.symptomatic treatment of mild to moderately severe alzheimer's dementia.symptomatic treatment of mild to moderately severe dementia associated with parkinson's disease.